| Type | Amino sulfonic acid |
| Active Cmpd | Taurine |
| Source | Meat, seafood, endogenous |
| Dose Range | 1,500–3,000 mg/day |
| Half-life | 1.0–1.5 hours (plasma) |
| Main Benefit | Cardiovascular & Metabolic health |
| Absorption | High (intestinal TAUT) |
Taurine is a non-proteinogenic sulfur-containing amino acid that serves as a critical regulator of cellular homeostasis, particularly in the cardiovascular and central nervous systems. Extensive meta-analytic evidence supports its efficacy in reducing blood pressure and improving glycemic control, while emerging network meta-analyses highlight its cognitive synergy when combined with caffeine [1][2][3].
Taurine is a conditionally essential amino acid derivative found at high concentrations in metabolically active tissues, including the heart, brain, retina, and skeletal muscle.
Taurine’s primary clinical value lies in its pleiotropic effects on cardiometabolic health and physical performance.
Meta-analyses consistently demonstrate that taurine supplementation reduces resting blood pressure. The magnitude of effect is clinically significant, with average reductions of approximately 4.0 mmHg in systolic and 1.5 mmHg in diastolic pressure across diverse populations [1:2][5:1]. It also improves left ventricular function and functional class (NYHA) in heart failure patients [1:3][12].
Taurine enhances insulin sensitivity and glycemic control. Clinical data show significant reductions in fasting blood glucose (average -5.90 mg/dL) and HbA1c (-0.21%), alongside improvements in lipid profiles (decreased triglycerides and total cholesterol) [2:3][6:1].
In the context of exercise, taurine reduces oxidative damage and muscle soreness while increasing physical capacity [7:1][13]. Notably, latest network meta-analyses identify that the combination of caffeine and taurine uniquely enhances cognitive ability beyond the capacity of individual stimulants [3:3].
| Outcome / Goal | Effect* | Consistency | Evidence quality | Trials | Notes (population, duration, dose) |
|---|---|---|---|---|---|
| Systolic Blood Pressure | High | High | 25+ RCTs | Significant reductions (-4.0 to -4.7 mmHg) across hypertensive and healthy cohorts [1:4][2:4] | |
| Fasting Blood Glucose | Moderate | Moderate | ~27 RCTs | Average reduction of 5.9 mg/dL in metabolic cohorts [2:5][6:2] | |
| HbA1c | Moderate | Moderate | ~27 RCTs | Significant decrease of 0.21% in diabetic and overweight adults [2:6][14] | |
| Triglycerides | Moderate | Moderate | Meta-analysis | Clinically meaningful reductions in overweight/obese populations [5:2][6:3] | |
| Cognitive Function | Moderate | Moderate | Network Meta | Synergistic benefit when combined with caffeine [3:4] | |
| Exercise Capacity | High | Moderate | Systematic Review | Improved endurance and reduced RPE in physical training [3:5][7:2] | |
| Heart Failure Symptoms | Moderate | Moderate | Systematic Review | Improvements in LVEF and NYHA functional classification [1:5][12:1] | |
| Colorectal Cancer Risk | Low | Very Low | Observational | Association noted in observational data; causality unproven [15] |
Taurine functions through several distinct but overlapping biological mechanisms that stabilize cellular environments.
Meta-analytic data from over 25 RCTs demonstrate that oral taurine significantly lowers systolic blood pressure (WMD = -3.99 to -4.67 mmHg) and diastolic blood pressure (WMD = -1.43 to -2.90 mmHg) [1:6][17]. In patients with dilated cardiomyopathy or congestive heart failure, taurine supplementation improves cardiac output, left ventricular ejection fraction (LVEF), and NYHA functional class [1:7][12:2].
Taurine supplementation significantly improves markers of metabolic syndrome. A 2025 meta-analysis reported reductions in fasting blood glucose (-5.90 mg/dL), fasting insulin, and HbA1c (-0.21%) [2:8]. Long-term supplementation (3,000 mg/day) in overweight or obese adults has been shown to decrease triglycerides and total cholesterol [6:4].
Taurine acts as a neuroprotective agent. While evidence for standalone cognitive enhancement in healthy humans is mixed, network meta-analysis shows that co-ingestion with caffeine significantly improves cognitive performance [3:6]. Preclinical reviews suggest potential benefits in Alzheimer's disease by ameliorating symptomatic presentation and neurochemical changes [18]. It also shows promise in mitigating symptoms of mood disorders in scoping reviews [17:1].
Taurine is characterized by an exceptionally high safety threshold.
Yes. Vegan diets are essentially devoid of taurine, and vegans often have lower plasma levels. Supplementation is an effective way to normalize taurine status in this population [9:4].
Taurine has GABAergic properties and may have a calming effect on the nervous system. While some users report better sleep quality, robust clinical trials specifically targeting sleep architecture are limited compared to its metabolic and cardiovascular data.
Evidence was evaluated using the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) framework.
Tzang CC, et al. Insights into the cardiovascular benefits of taurine: a systematic review and meta-analysis. Nutrition journal. 2024. https://pubmed.ncbi.nlm.nih.gov/39148075/ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Nie Z, et al. Effects of Oral Taurine Supplementation on Cardiometabolic Risk Factors: A Meta-analysis and Systematic Review of Randomized Clinical Trials. Nutrition reviews. 2025. https://pubmed.ncbi.nlm.nih.gov/41275513/ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Deng H, et al. Caffeine and taurine: a systematic review and network meta-analysis of their individual and combined effects on physical capacity, cognitive function, and physiological markers. Journal of the International Society of Sports Nutrition. 2025. https://pubmed.ncbi.nlm.nih.gov/41032459/ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Guan L, Miao P. The effects of taurine supplementation on obesity, blood pressure and lipid profile: A meta-analysis of randomized controlled trials. European journal of pharmacology. 2020. https://pubmed.ncbi.nlm.nih.gov/32871172/ ↩︎
Tzang CC, et al. Taurine reduces the risk for metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials. Nutrition & diabetes. 2024. https://pubmed.ncbi.nlm.nih.gov/38755142/ ↩︎ ↩︎ ↩︎ ↩︎
Sun Q, et al. Effect of Long-Term Taurine Supplementation on the Lipid and Glycaemic Profile in Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis. Nutrients. 2024. https://pubmed.ncbi.nlm.nih.gov/39796489/ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Chen Q, et al. The Dose Response of Taurine on Aerobic and Strength Exercises: A Systematic Review. Frontiers in physiology. 2021. https://pubmed.ncbi.nlm.nih.gov/34497536/ ↩︎ ↩︎ ↩︎ ↩︎
Keshavarzi M, et al. A narrative review and new insights into the protective effects of taurine against drug side effects. Naunyn-Schmiedeberg's archives of pharmacology. 2025. https://pubmed.ncbi.nlm.nih.gov/39141023/ ↩︎ ↩︎ ↩︎
Oja SS, Saransaari P. Taurine and the Brain. Advances in experimental medicine and biology. 2022. https://pubmed.ncbi.nlm.nih.gov/35882807/ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Cao SL, et al. Effects of Taurine Supplementation on Growth in Low Birth Weight Infants: A Systematic Review and Meta-Analysis. Indian journal of pediatrics. 2018. https://pubmed.ncbi.nlm.nih.gov/29368111/ ↩︎ ↩︎
Faghfouri AH, et al. Profiling inflammatory and oxidative stress biomarkers following taurine supplementation: a systematic review and dose-response meta-analysis of controlled trials. European journal of clinical nutrition. 2022. https://pubmed.ncbi.nlm.nih.gov/34584225/ ↩︎ ↩︎ ↩︎
McGurk KA, et al. Effect of taurine administration on symptoms, severity, or clinical outcome of dilated cardiomyopathy and heart failure in humans: a systematic review. Wellcome open research. 2022. https://pubmed.ncbi.nlm.nih.gov/35855073/ ↩︎ ↩︎ ↩︎
Kurtz JA, et al. Taurine in sports and exercise. Journal of the International Society of Sports Nutrition. 2021. https://pubmed.ncbi.nlm.nih.gov/34039357/ ↩︎ ↩︎
Tao X, et al. The effects of taurine supplementation on diabetes mellitus in humans: A systematic review and meta-analysis. Food chemistry. Molecular sciences. 2022. https://pubmed.ncbi.nlm.nih.gov/35769396/ ↩︎
Sinha A, et al. Systematic Review and Meta-Analysis: Taurine and Its Association With Colorectal Carcinoma. Cancer medicine. 2024. https://pubmed.ncbi.nlm.nih.gov/39632512/ ↩︎ ↩︎
Li XW, et al. The role of taurine in improving neural stem cells proliferation and differentiation. Nutritional neuroscience. 2017. https://pubmed.ncbi.nlm.nih.gov/26906683/ ↩︎
Pedregosa BIC, et al. Therapeutic Potential of Gotu Kola (Centella asiatica), Phosphatidylcholine, and Taurine in Mood Disorders: A Systematic Scoping Review. Complementary medicine research. 2026. https://pubmed.ncbi.nlm.nih.gov/42391143/ ↩︎ ↩︎
Aamer H, et al. Exploring Taurine's Potential in Alzheimer's Treatment: A Comprehensive Review. Cureus. 2024. https://pubmed.ncbi.nlm.nih.gov/38910611/ ↩︎
Zhang C, et al. Efficacy of taurine-enhanced enteral nutrition in improving the outcomes of critically ill patients: A systematic review and meta-analysis. Clinical nutrition ESPEN. 2024. https://pubmed.ncbi.nlm.nih.gov/38777434/ ↩︎
Naraki K, et al. The Protective Effects of Taurine, a Non-essential Amino Acid, Against Metals Toxicities: A Review Article. Biological trace element research. 2025. https://pubmed.ncbi.nlm.nih.gov/38735894/ ↩︎
Malek Mahdavi A, et al. Taurine supplementation and systemic lupus erythematosus in preclinical studies: a systematic review of clinical outcomes and underlying mechanisms. Amino acids. 2026. https://pubmed.ncbi.nlm.nih.gov/41874670/ ↩︎
Malek Mahdavi A, Javadivala Z. A systematic review of preclinical studies on the efficacy of taurine for the treatment of rheumatoid arthritis. Amino acids. 2021. https://pubmed.ncbi.nlm.nih.gov/33929638/ ↩︎